日本软组织肉瘤:2016年至2019年基于国家癌症注册表的分析
Koichi Ogura1, Chigusa Morizane2, Tomoyuki Satake3
1Department of Musculoskeletal Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Japanese journal of clinical oncology
|July 6, 2024
概括
这项研究详细介绍了日本软组织肉瘤 (STS) 国家统计数据,揭示了关键的流行病学和预后因素. 这些发现突出了与患者和瘤特征的生存关联,为未来的研究和患者护理提供了信息.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 此前没有软组织肉瘤 (STS) 的国家特征.
- 这项研究利用日本国家癌症登记处的全国性STS统计数据.
研究的目的:
- 概述日本STS的流行病学,临床特征,治疗和预后.
- 确定影响STS预后的重要因素.
主要方法:
- 从国家癌症登记处 (2016-2019) 分析了23,522名STS患者.
- 数据提取包括人口统计,瘤细节,医院特征,治疗和结果.
- 国际疾病分类-瘤学,第三版代码用于患者识别.
主要成果:
- STS显示轻微男性占主导地位,年龄调整后的发病率为3.22/100,000/年.
- 脂质肉瘤是最常见的亚型;常见的位置包括软组织,皮肤和后皮质.
- 存活率与性别,年龄,瘤位置,设施类型,医院容量,诊断原因,疾病程度和手术治疗有显著联系.
结论:
- 这是使用国家注册数据的日本STS的首份综合报告.
- 调查结果为了解STS提供了必要的数据,并为全球人口老龄化策略提供了信息.
相关概念视频
Cancer Survival Analysis
340
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
340
Rous Sarcoma Virus (RSV) and Cancer
5.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.0K


